{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:45:17Z","timestamp":1790963117259,"version":"4.1.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2001,4,1]],"date-time":"2001-04-01T00:00:00Z","timestamp":986083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2001,4,1]],"date-time":"2001-04-01T00:00:00Z","timestamp":986083200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2001,4]]},"DOI":"10.1007\/s11910-001-0012-z","type":"journal-article","created":{"date-parts":[[2007,6,28]],"date-time":"2007-06-28T06:05:03Z","timestamp":1183010703000},"page":"162-167","source":"Crossref","is-referenced-by-count":45,"title":["Diagnosis and management of neurofibromatosis type 1"],"prefix":"10.1007","volume":"1","author":[{"given":"Bruce R.","family":"Korf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"12_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/(SICI)1096-8628(19990326)89:1<1::AID-AJMG3>3.0.CO;2-8","volume":"89","author":"JM Friedman","year":"1999","unstructured":"Friedman JM: Epidemiology of neurofibromatosis type 1. Am J Med Genet 1999, 89:1\u20136.","journal-title":"Am J Med Genet"},{"key":"12_CR2","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1001\/archneur.1988.00520290115023","volume":"45","author":"DA Stumpf","year":"1988","unstructured":"Stumpf DA, Alksne JF, Annegers JF, et al.: Neurofibromataosis. Arch Neurol 1988, 45:575\u2013578.","journal-title":"Arch Neurol"},{"key":"12_CR3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1001\/jama.278.1.51","volume":"278","author":"DH Gutmann","year":"1997","unstructured":"Gutmann DH, Aylsworth A, Carey JC, et al.: The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 1997, 278:51\u201357.","journal-title":"JAMA"},{"key":"12_CR4","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1542\/peds.105.3.608","volume":"105","author":"K DeBella","year":"2000","unstructured":"DeBella K, Szudek J, Friedman JM: Use of the national institutes of health criteria for diagnosis of neurofibromatosis 1 in children. Pediatrics 2000, 105:608\u2013614.","journal-title":"Pediatrics"},{"key":"12_CR5","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1212\/WNL.54.8.1646","volume":"54","author":"K DeBella","year":"2000","unstructured":"DeBella K, Poskitt K, Szudek J, Friedman JM: Use of \u201cunidentified bright objects\u201d on MRI for diagnosis of neurofibromatosis 1 in children. Neurology 2000, 54:1646\u20131651.","journal-title":"Neurology"},{"key":"12_CR6","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/1096-8628(20000717)93:2<136::AID-AJMG11>3.0.CO;2-L","volume":"93","author":"J Ablon","year":"2000","unstructured":"Ablon J: Parents\u2019 responses to their child\u2019s diagnosis of neurofibromatosis 1. Am J Med Genet 2000, 93:136\u2013142.","journal-title":"Am J Med Genet"},{"key":"12_CR7","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1002\/1098-1004(200006)15:6<541::AID-HUMU6>3.0.CO;2-N","volume":"15","author":"LM Messiaen","year":"2000","unstructured":"Messiaen LM, Callens T, Mortier G, et al.: Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects. Hum Mutat 2000, 15:541\u2013555. This paper demonstrates that use of a multistep process can result in a high rate of detection of NF1 gene mutations. Although the process is laborious, it offers an approach that may result in a diagnostic test for neurofibromatosis type 1.","journal-title":"Hum Mutat"},{"key":"12_CR8","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1086\/302809","volume":"66","author":"R Fahsold","year":"2000","unstructured":"Fahsold R, Hoffmeyer S, Mischung C, et al.: Minor lesion mutational spectrum of the entire NF1 gene does not explain its high mutability but points to a functional domain upstream of the GAP-related domain. Am J Hum Genet 2000, 66:790\u2013818. This is the largest set of NF1 mutations reported to date. The clustering of missense mutations between exons 11\u201317 suggests the occurrence of a functional domain other than the GAP-related domain.","journal-title":"Am J Hum Genet"},{"key":"12_CR9","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/(SICI)1098-1004(199912)14:6<520::AID-HUMU11>3.0.CO;2-K","volume":"14","author":"CC Lopez","year":"1999","unstructured":"Lopez CC, Brems H, Lazaro C, et al.: Molecular studies in 20 submicroscopic neurofibromatosis type 1 gene deletions. Hum Mutat 1999, 14:387\u2013393.","journal-title":"Hum Mutat"},{"key":"12_CR10","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1006\/geno.2000.6179","volume":"66","author":"DE Jenne","year":"2000","unstructured":"Jenne DE, Tinschert S, Stegmann E, et al.: A common set of at least 11 functional genes is lost in the majority of NF1 patients with gross deletions. Genomics 2000, 66:93\u201397.","journal-title":"Genomics"},{"key":"12_CR11","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1086\/302920","volume":"66","author":"CL Correa","year":"2000","unstructured":"Correa CL, Brems H, Lazaro C, et al.: Unequal meiotic crossover: a frequent cause of NF1 microdeletions. Am J Hum Genet 2000, 66:1969\u20131974. This paper provides a likely explanation for the etiology of large NF1 deletions by unequal crossing over between two repeated sequences.","journal-title":"Am J Hum Genet"},{"key":"12_CR12","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1086\/302709","volume":"66","author":"P Riva","year":"2000","unstructured":"Riva P, Corrado L, Natacci F, et al.: NF1 microdeletion syndrome: refined FISH characterization of sporadic and familial deletions with locus-specific probes. Am J Hum Genet 2000, 66:100\u2013109.","journal-title":"Am J Hum Genet"},{"key":"12_CR13","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1093\/hmg\/9.1.35","volume":"9","author":"MO Dorschner","year":"2000","unstructured":"Dorschner MO, Sybert VP, Weaver M, et al.: NF1 microdeletion breakpoints are clustered at flanking repetitive sequences. Hum Mol Genet 2000, 9:35\u201346.","journal-title":"Hum Mol Genet"},{"key":"12_CR14","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/sj.ejhg.5200493","volume":"8","author":"S Tinschert","year":"2000","unstructured":"Tinschert S, Naumann I, Stegmann E, et al.: Segmental neurofibromatosis is caused by somatic mutation of the neurofibromatosis type 1 (NF1) gene. Eur J Hum Genet 2000, 8:455\u2013459.","journal-title":"Eur J Hum Genet"},{"key":"12_CR15","first-page":"197","volume":"36","author":"JM McGaughran","year":"1999","unstructured":"McGaughran JM, Harris DI, Donnai D, et al.: A clinical study of type 1 neurofibromatosis in north west England. J Med Genet 1999, 36:197\u2013203.","journal-title":"J Med Genet"},{"key":"12_CR16","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s002340050814","volume":"41","author":"SD Thakkar","year":"1999","unstructured":"Thakkar SD, Feigen U, Mautner VF: Spinal tumours in neurofibromatosis type 1: an MRI study of frequency, multiplicity and variety. Neuroradiology 1999, 41:625\u2013629.","journal-title":"Neuroradiology"},{"key":"12_CR17","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s002470050605","volume":"29","author":"CJ Chung","year":"1999","unstructured":"Chung CJ, Armfield KB, Mukherji SK, et al.: Cervical neurofibromas in children with NF-1. Pediatr Radiol 1999, 29:353\u2013356.","journal-title":"Pediatr Radiol"},{"key":"12_CR18","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1093\/brain\/122.3.473","volume":"122","author":"A Creange","year":"1999","unstructured":"Creange A, Zeller J, Rostaing-Rigattieri S, et al.: Neurological complications of neurofibromatosis type 1 in adulthood. Brain 1999, 122(Pt 3):473\u2013481.","journal-title":"Brain"},{"key":"12_CR19","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/088307380001500406","volume":"15","author":"FJ DiMario Jr","year":"2000","unstructured":"DiMario FJ Jr, Langshur S: Headaches in patients with neurofibromatosis-1. J Child Neurol 2000, 15:235\u2013238.","journal-title":"J Child Neurol"},{"key":"12_CR20","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1053\/ejso.1998.0625","volume":"25","author":"RC Ramanathan","year":"1999","unstructured":"Ramanathan RC, Thomas JM: Malignant peripheral nerve sheath tumours associated with von Recklinghausen\u2019s neurofibromatosis. Eur J Surg Oncol 1999, 25:190\u2013193.","journal-title":"Eur J Surg Oncol"},{"key":"12_CR21","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1136\/jnnp.68.3.353","volume":"68","author":"RE Ferner","year":"2000","unstructured":"Ferner RE, Lucas JD, O\u2019Doherty MJ, et al.: Evaluation of (18)fluorodeoxyglucose positron emission tomography ((18)FDG PET) in the detection of malignant peripheral nerve sheath tumours arising from within plexiform neurofibromas in neurofibromatosis 1. J Neurol Neurosurg Psychiatry 2000, 68:353\u2013357. If confirmed, this could result in a method of distinguishing benign from malignant peripheral nerve sheath tumors.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12_CR22","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1023\/A:1006338322266","volume":"45","author":"R Listernick","year":"1999","unstructured":"Listernick R, Charrow J, Tomita T, Goldman S: Carboplatin therapy for optic pathway tumors in children with neurofibromatosis type-1. J Neurooncol 1999, 45:185\u2013190.","journal-title":"J Neurooncol"},{"key":"12_CR23","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/(SICI)1096-8628(20000529)92:3<224::AID-AJMG12>3.0.CO;2-J","volume":"92","author":"J Zudek","year":"2000","unstructured":"Zudek J, Birch P, Friedman JM: Growth charts for young children with neurofibromatosis 1 (NF1) [letter]. Am J Med Genet 2000, 92:224\u2013228.","journal-title":"Am J Med Genet"},{"key":"12_CR24","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/(SICI)1096-8628(19991203)87:4<317::AID-AJMG7>3.0.CO;2-X","volume":"87","author":"M Clementi","year":"1999","unstructured":"Clementi M, Milani S, Mammi I, et al.: Neurofibromatosis type 1 growth charts. Am J Med Genet 1999, 87:317\u2013323.","journal-title":"Am J Med Genet"},{"key":"12_CR25","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1542\/peds.103.6.1257","volume":"103","author":"D Carmi","year":"1999","unstructured":"Carmi D, Shohat M, Metzker A, Dickerman Z: Growth, puberty, and endocrine functions in patients with sporadic or familial neurofibromatosis type 1: a longitudinal study. Pediatrics 1999, 103:1257\u20131262.","journal-title":"Pediatrics"},{"key":"12_CR26","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/00007632-200001010-00013","volume":"25","author":"AA Durrani","year":"2000","unstructured":"Durrani AA, Crawford AH, Chouhdry SN, et al.: Modulation of spinal deformities in patients with neurofibromatosis type 1. Spine 2000, 25:69\u201375.","journal-title":"Spine"},{"key":"12_CR27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/01202412-200001000-00002","volume":"9","author":"E Ippolito","year":"2000","unstructured":"Ippolito E, Corsi A, Grill F, et al.: Pathology of bone lesions associated with congenital pseudarthrosis of the leg. J Pediatr Orthop 2000, 9:3\u201310.","journal-title":"J Pediatr Orthop"},{"key":"12_CR28","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1002\/(SICI)1096-8628(19990611)84:5<413::AID-AJMG5>3.0.CO;2-1","volume":"84","author":"DA Stevenson","year":"1999","unstructured":"Stevenson DA, Birch PH, Friedman JM, et al.: Descriptive analysis of tibial pseudarthrosis in patients with neurofibromatosis 1. Am J Med Genet 1999, 84:413\u2013419.","journal-title":"Am J Med Genet"},{"key":"12_CR29","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3109\/17453679908997807","volume":"70","author":"ES Heikkinen","year":"1999","unstructured":"Heikkinen ES, Poyhonen MH, Kinnunen PK, Seppanen UI: Congenital pseudarthrosis of the tibia. Treatment and outcome at skeletal maturity in 10 children. Acta Orthop Scand 1999, 70:275\u2013282.","journal-title":"Acta Orthop Scand"},{"key":"12_CR30","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1207\/S15326942DN1701_02","volume":"17","author":"LE Cutting","year":"2000","unstructured":"Cutting LE, Koth CW, Denckla MB: How children with neurofibromatosis type 1 differ from \u201ctypical\u201d learning disabled clinic attenders: nonverbal learning disabilities revisited. Dev Neuropsychol 2000, 17:29\u201347. This is a thorough and careful study of the characteristics of learning disabilities in children with NF1.","journal-title":"Dev Neuropsychol"},{"key":"12_CR31","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/S0022-3476(99)70296-9","volume":"134","author":"NS Johnson","year":"1999","unstructured":"Johnson NS, Saal HM, Lovell AM, Schorry EK: Social and emotional problems in children with neurofibromatosis type 1: evidence and proposed interventions. J Pediatr 1999, 134:767\u2013772.","journal-title":"J Pediatr"},{"key":"12_CR32","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0022-3956(98)00052-1","volume":"33","author":"ME Zoller","year":"1999","unstructured":"Zoller ME, Rembeck B: A psychiatric 12-year follow-up of adult patients with neurofibromatosis type 1. J Psychiatr Res 1999, 33:63\u201368.","journal-title":"J Psychiatr Res"},{"key":"12_CR33","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/088307380001500303","volume":"15","author":"LE Cutting","year":"2000","unstructured":"Cutting LE, Koth CW, Burnette CP, et al.: Relationship of cognitive functioning, whole brain volumes, and T2-weighted hyperintensities in neurofibromatosis-1. J Child Neurol 2000, 15:157\u2013160.","journal-title":"J Child Neurol"},{"key":"12_CR34","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1212\/WNL.54.4.914","volume":"54","author":"BD Moore III","year":"2000","unstructured":"Moore BD III, Slopis JM, Jackson EF, et al.: Brain volume in children with neurofibromatosis type 1: relation to neuropsychological status. Neurology 2000, 54:914\u2013920.","journal-title":"Neurology"},{"key":"12_CR35","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1177\/088307380001500206","volume":"15","author":"AE Kayl","year":"2000","unstructured":"Kayl AE, Moore BD III, Slopis JM, et al.: Quantitative morphology of the corpus callosum in children with neurofibromatosis and attention-deficit hyperactivity disorder. J Child Neurol 2000, 15:90\u201396.","journal-title":"J Child Neurol"},{"key":"12_CR36","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1001\/archneur.56.11.1343","volume":"56","author":"FJ DiMario Jr.","year":"1999","unstructured":"DiMario FJ Jr., Ramsby GR, Burleson JA: Brain morphometric analysis in neurofibromatosis 1 [comment]. Arch.Neurol 1999, 56:1343\u20131346.","journal-title":"Arch.Neurol"},{"key":"12_CR37","doi-asserted-by":"publisher","first-page":"e49","DOI":"10.1542\/peds.104.4.e49","volume":"104","author":"PD Griffiths","year":"1999","unstructured":"Griffiths PD, Blaser S, Mukonoweshuro W, et al.: Neurofibromatosis bright objects in children with neurofibromatosis type 1: a proliferative potential? Pediatrics 1999, 104:e49.","journal-title":"Pediatrics"},{"key":"12_CR38","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/1098-2264(200008)28:4<425::AID-GCC8>3.0.CO;2-E","volume":"28","author":"SA Rasmussen","year":"2000","unstructured":"Rasmussen SA, Overman J, Thomson SA, et al.: Chromosome 17 loss-of-heterozygosity studies in benign and malignant tumors in neurofibromatosis type 1. Genes Chrom Cancer 2000, 28:425\u2013431.","journal-title":"Genes Chrom Cancer"},{"key":"12_CR39","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1086\/302747","volume":"66","author":"I Eisenbarth","year":"2000","unstructured":"Eisenbarth I, Beyer K, Krone W, Assum G: Toward a survey of somatic mutation of the NF1 gene in benign neurofibromas of patients with neurofibromatosis type 1. Am J Hum Genet 2000, 66:393\u2013401.","journal-title":"Am J Hum Genet"},{"key":"12_CR40","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/(SICI)1098-2264(199903)24:3<283::AID-GCC15>3.0.CO;2-K","volume":"24","author":"L Kluwe","year":"1999","unstructured":"Kluwe L, Friedrich R, Mautner VF: Loss of NF1 allele in Schwann cells but not in fibroblasts derived from an NF1-associated neurofibroma. Genes Chrom Cancer 1999, 24:283\u2013285. This paper provides some of the first evidence that it is the Schwann cell that is the primary neoplastic cell in a neurofibroma.","journal-title":"Genes Chrom Cancer"},{"key":"12_CR41","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1093\/hmg\/9.7.1059","volume":"9","author":"JL Rutkowski","year":"2000","unstructured":"Rutkowski JL, Wu K, Gutmann DH, et al.: Genetic and cellular defects contributing to benign tumor formation in neurofibromatosis type 1. Hum Mol Genet 2000, 9:1059\u20131066. This paper provides some of the first evidence that it is the Schwann cell that is the primary neoplastic cell in a neurofibroma.","journal-title":"Hum Mol Genet"},{"key":"12_CR42","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0090-3019(97)00356-X","volume":"51","author":"MM Feldkamp","year":"1999","unstructured":"Feldkamp MM, Angelov L, Guha A: Neurofibromatosis type 1 peripheral nerve tumors: aberrant activation of the Ras pathway. Surg Neurol 1999, 51:211\u2013218.","journal-title":"Surg Neurol"},{"key":"12_CR43","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1126\/science.286.5447.2172","volume":"286","author":"K Cichowski","year":"1999","unstructured":"Cichowski K, Shih TS, Schmitt E, et al.: Mouse models of tumor development in neurofibromatosis type 1. Science 1999, 286:2172\u20132176. This paper describes the mouse knockout models of NF1, which have provided major insights into the pathogenesis of the disorders.","journal-title":"Science"},{"key":"12_CR44","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1126\/science.286.5447.2176","volume":"286","author":"KS Vogel","year":"1999","unstructured":"Vogel KS, Klesse LJ, Velasco-Miguel S, et al.: Mouse tumor model for neurofibromatosis type 1. Science 1999, 286:2176\u20132179. This paper describes the mouse knockout models of NF1, which have provided major insights into the pathogenesis of the disorders.","journal-title":"Science"},{"key":"12_CR45","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1046\/j.1523-1747.1999.00609.x","volume":"112","author":"RP Atit","year":"1999","unstructured":"Atit RP, Crowe MJ, Greenhalgh DG, et al.: The Nf1 tumor suppressor regulates mouse skin wound healing, fibroblast proliferation, and collagen deposited by fibroblasts. J Invest Dermatol 1999, 112:835\u2013842. This paper provides evidence for a heterozygous effect of NF1 mutation.","journal-title":"J Invest Dermatol"},{"key":"12_CR46","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1084\/jem.191.1.181","volume":"191","author":"DA Ingram","year":"2000","unstructured":"Ingram DA, Yang FC, Travers JB, et al.: Genetic and biochemical evidence that haploinsufficiency of the Nf1 tumor suppressor gene modulates melanocyte and mast cell fates in vivo. J Exp Med 2000, 191:181\u2013188. This paper provides evidence for a heterozygous effect of NF1 mutation.","journal-title":"J Exp Med"},{"key":"12_CR47","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S1097-2765(00)80415-3","volume":"5","author":"RA Birnbaum","year":"2000","unstructured":"Birnbaum RA, O\u2019Marcaigh A, Wardak Z, et al.: Nf1 and Gmcsf interact in myeloid leukemogenesis. Mol Cell 2000, 5:189\u2013195.","journal-title":"Mol Cell"},{"key":"12_CR48","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1172\/JCI7610","volume":"105","author":"JE DeClue","year":"2000","unstructured":"DeClue JE, Heffelfinger S, Benvenuto G, et al.: Epidermal growth factor receptor expression in neurofibromatosis type 1-related tumors and NF1 animal models. J Clin Invest 2000, 105:1233\u20131241.","journal-title":"J Clin Invest"},{"key":"12_CR49","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1046\/j.1523-1747.1999.00699.x","volume":"113","author":"GA Mashour","year":"1999","unstructured":"Mashour GA, Wang HL, Cabal-Manzano R, et al.: Aberrant cutaneous expression of the angiogenic factor midkine is associated with neurofibromatosis type-1. J Invest Dermatol 1999, 113:398\u2013402.","journal-title":"J Invest Dermatol"},{"key":"12_CR50","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/35002593","volume":"403","author":"HF Guo","year":"2000","unstructured":"Guo HF, Tong J, Hannan F, et al.: A neurofibromatosis-1-regulated pathway is required for learning in Drosophila [comment]. Nature 2000, 403:895\u2013898.","journal-title":"Nature"},{"key":"12_CR51","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1182\/blood.V94.7.2469.419a01_2469_2476","volume":"94","author":"N Mahgoub","year":"1999","unstructured":"Mahgoub N, Taylor BR, Gratiot M, et al.: In vitro and in vivo effects of a farnesyltransferase inhibitor on NF1-deficient hematopoietic cells. Blood 1999, 94:2469\u20132476.","journal-title":"Blood"},{"key":"12_CR52","first-page":"1871","volume":"60","author":"AA Adjei","year":"2000","unstructured":"Adjei AA, Erlichman C, Davis JN, et al.: A Phase I trial of the farnesyl transferase inhibitor SCH66336: evidence for biological and clinical activity. Cancer Res 2000, 60:1871\u20131877.","journal-title":"Cancer Res"},{"key":"12_CR53","first-page":"292","volume":"7","author":"OG Scharovsky","year":"2000","unstructured":"Scharovsky OG, Rozados VR, Gervasoni SI, Matar P: Inhibition of ras oncogene: A novel approach to antineoplastic therapy. J Biomed Sci 2000, 7:292\u2013298.","journal-title":"J Biomed Sci"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-001-0012-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11910-001-0012-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-001-0012-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-001-0012-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,15]],"date-time":"2022-05-15T13:05:38Z","timestamp":1652619938000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11910-001-0012-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,4]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,4]]}},"alternative-id":["12"],"URL":"https:\/\/doi.org\/10.1007\/s11910-001-0012-z","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,4]]}}}